U.S. President Biden signed a bill last Thursday postponing the sunset date of the rare pediatric disease Priority Review Voucher (PRV) program from September 30, 2024, to December 20, 2024. The bill, ...

(RTTNews) - Indivior Plc.(INDV) announced that the U.S. Food and Drug Administration has granted Priority Review designation for the Prior Approval Supplement of SUBLOCADE (buprenorphine ...

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of breast ...

Acalabrutinib, a BTK inhibitor, has shown promising results in treating mantle cell lymphoma, with the FDA granting it ...

If you’re looking for a Southwest credit card that offers the upmost perks, then the Southwest Rapid Rewards® Priority Credit Card is by far your best bet. Of course, its annual fee is on the ...

Acalabrutinib, a Bruton tyrosine kinase inhibitor, is currently approved under the brand name Calquence ® for MCL in patients who have received at least 1 prior therapy. It is also indicated for the ...

If you’re looking for a flexible home warranty provider at an affordable price point, learn more about Priority Home Warranty’s coverage options in this review by the Guides Home Team.

The government said the New Hospital Programme was under review because of funding constraints. Chief executive of the Royal ...

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...